Programs and Projects
Uterine Cancer Prevention Clinical Trials
Ongoing Phase II Prevention Trials Monitored by the Breast and Gynecologic Cancer Research Group (BGCRG)
Contracts
| Principal Investigator |
Institution |
Title of Award |
Chemopreventive Agent |
BGCRG Medical Monitor |
| Karen Lu, M.D. |
University of Texas, M D Anderson Cancer Center |
Modulation of Putative Endpoint Biomarkers in Endometrial Biopsies from Women with HNPCC |
DepoProvera/ LoOvral |
Terri Cornelison, M.D. |
|
** indicates that the contract/cooperative agreements are open to accrual
The University of Texas MD Anderson Cancer Center: Hereditary Gynecologic Cancers
This page was last updated on June 15, 2008.
